Skip to content
NEWSnet Monterey
    • Homepage
Tigerlily Foundation Celebrates FDA Approval of Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer

Author: Tigerlily Foundation

Posted Date:

June 25, 2026
  • Tigerlily Foundation Celebrates FDA Approval of Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer

    Tigerlily Foundation
    June 25, 2026
  • Introducing the Tigerlily Foundation EmpowerHER Peer Navigation Program

    Tigerlily Foundation
    May 20, 2026
  • Tigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity

    Tigerlily Foundation
    May 15, 2026
  • Tigerlily Foundation Continues the Bliss Collective: Brunch & Sip Series with Upcoming Events in Atlanta and Miami

    Tigerlily Foundation
    March 31, 2026